ATE259233T1 - Lamivudin enthaltende arzneimittel - Google Patents

Lamivudin enthaltende arzneimittel

Info

Publication number
ATE259233T1
ATE259233T1 AT00917372T AT00917372T ATE259233T1 AT E259233 T1 ATE259233 T1 AT E259233T1 AT 00917372 T AT00917372 T AT 00917372T AT 00917372 T AT00917372 T AT 00917372T AT E259233 T1 ATE259233 T1 AT E259233T1
Authority
AT
Austria
Prior art keywords
products containing
medicinal products
containing lamivudine
lamivudine
medicinal
Prior art date
Application number
AT00917372T
Other languages
English (en)
Inventor
Koho Kawamura
Toshio Maruyama
Yasuhiro Mishima
Nobuya Sugibayashi
Original Assignee
Glaxosmithkline Kabushiki Kais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Kabushiki Kais filed Critical Glaxosmithkline Kabushiki Kais
Application granted granted Critical
Publication of ATE259233T1 publication Critical patent/ATE259233T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00917372T 1999-04-22 2000-04-20 Lamivudin enthaltende arzneimittel ATE259233T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909154.8A GB9909154D0 (en) 1999-04-22 1999-04-22 Pharmaceutical formulation
PCT/JP2000/002572 WO2000064427A2 (en) 1999-04-22 2000-04-20 Lamivudine containing pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ATE259233T1 true ATE259233T1 (de) 2004-02-15

Family

ID=10851982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00917372T ATE259233T1 (de) 1999-04-22 2000-04-20 Lamivudin enthaltende arzneimittel

Country Status (9)

Country Link
EP (1) EP1180033B1 (de)
JP (1) JP2002542283A (de)
AR (1) AR023573A1 (de)
AT (1) ATE259233T1 (de)
AU (1) AU3839900A (de)
DE (1) DE60008237T2 (de)
ES (1) ES2214262T3 (de)
GB (1) GB9909154D0 (de)
WO (1) WO2000064427A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855346B2 (en) 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
EP3025718A1 (de) 2003-01-14 2016-06-01 Gilead Sciences, Inc. Zusammensetzungen und verfahren für antivirale kombinationstherapie
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
SI2225232T1 (sl) * 2007-11-29 2012-12-31 Ranbaxy Laboratories Limited Postopek za pripravo substituiranih 1,3-oksatiolanov
EP2435052B1 (de) 2009-05-27 2015-07-15 Hetero Research Foundation Feste orale lamivudin-darreichgungsformen mit isomalt
CN102167696B (zh) * 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000837A1 (en) * 1985-07-29 1987-02-12 Santen Pharmaceutical Co., Ltd Novel benzothiazine derivatives
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
JPS63280025A (ja) * 1987-05-13 1988-11-17 Taisho Pharmaceut Co Ltd 吸収促進製剤の製造方法
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
JP2814296B2 (ja) * 1990-07-02 1998-10-22 大鵬薬品工業株式会社 ２―ニトロイミダゾール誘導体及びそれを含有する抗原虫剤
JP3667359B2 (ja) * 1993-12-29 2005-07-06 扶桑薬品工業株式会社 ５−フルオロウリジン誘導体の製造および医薬組成物
GB9517022D0 (en) * 1995-08-19 1995-10-25 Glaxo Group Ltd Medicaments
JP3718890B2 (ja) * 1995-12-28 2005-11-24 味の素株式会社 Ｎ−ベンゾイルプロリンエステル誘導体
JPH09323932A (ja) * 1996-01-31 1997-12-16 Sankyo Co Ltd エイズ治療剤又は予防剤
AU712071B2 (en) * 1996-04-04 1999-10-28 Shionogi & Co., Ltd. Anti-HIV composition containing imidazole derivatives
JP3652708B2 (ja) * 1997-03-06 2005-05-25 トーアエイヨー株式会社 シクロアルカ［ｂ］ピリジン−３−カルボニルグアニジン誘導体、その製造法およびそれを含有する医薬品

Also Published As

Publication number Publication date
EP1180033B1 (de) 2004-02-11
AR023573A1 (es) 2002-09-04
WO2000064427A3 (en) 2001-12-06
DE60008237T2 (de) 2004-12-09
ES2214262T3 (es) 2004-09-16
WO2000064427A2 (en) 2000-11-02
AU3839900A (en) 2000-11-10
GB9909154D0 (en) 1999-06-16
EP1180033A2 (de) 2002-02-20
DE60008237D1 (de) 2004-03-18
JP2002542283A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
ATE240732T1 (de) Ziprasidonhaltige arzneimittel
ATE318137T1 (de) Parenteral anzuwendendes bisphosphonathaltiges arzneimittel
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
ATE217794T1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
NO20005218D0 (no) Farmasøytisk aerosolpreparat
ATE352339T1 (de) Medikamentspender
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE60004685D1 (de) Pyrazolopyrimidine als arzneimittel
DE69513671D1 (de) Arzneimittel
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
NO20020531D0 (no) Beta-carbolin medikament produkter
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
ID27150A (id) Sediaan levotiroksin bahan farmasi
NO20014926D0 (no) Farmasöytiske forbindelser
ATE359085T1 (de) Arzneimittel enthaltend aktiviertes antithrombin iii
ATE384517T1 (de) Orales arzneimittel mit verzögerter wirkstoffabgabe
ATE259233T1 (de) Lamivudin enthaltende arzneimittel
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
NO20016430D0 (no) Farmasöytisk kompleks
DE69819203D1 (de) Trinkbares arzneimittel
DE50008261D1 (de) Retardierte darreichungsform enthaltend tramadolsaccharinat
ATA12192000A (de) Antimykotisch wirkendes arzneimittel
SE9800267D0 (sv) Läkemedelsförpackning
ATE332709T1 (de) Stabilisiertes arzneimittel enthaltend cysteinylderivate
UA3066S (uk) Упаковка медичного препарату

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties